About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » Drug News

Drug News

Total No. of Records - 8608 Page - 1 of 861
Drug news covers the latest breakthroughs in pharmaceuticals, including new drug approvals, clinical trial results, and advancements in drug delivery systems. It also delves into discussions about drug safety, pricing, and access to medications.

Obesity Medication Awareness: Women Are More Informed Than Men

Obesity Medication Awareness: Women Are More Informed Than Men

Increased awareness and knowledge of GLP-1/GIP receptor agonists among women, with insights into public perspectives on obesity drugs.

Adults With Cerebral Palsy: Are Their Medications Meeting Their Needs?

Adults With Cerebral Palsy: Are Their Medications Meeting Their Needs?

Medications for adults with cerebral palsy often fail to address their specific pain and symptom needs.

GLP1 Agonists and Depression: New Study Sparks Urgent Safety Concerns

GLP1 Agonists and Depression: New Study Sparks Urgent Safety Concerns

New study finds potential link between GLP1 agonists and depression, urging further investigation into patient safety.

Advertisement

Future of Solengepras in Parkinson's Disease: Strong Potential as Add-On Therapy

Future of Solengepras in Parkinson's Disease: Strong Potential as Add-On Therapy

Solengepras shows strong potential as an adjunctive therapy for Parkinson’s, offering a novel, well-tolerated option with promising clinical results.

Tirzepatide: Combating Obesity, Kidney Disease, and Heart Failure Together

Tirzepatide: Combating Obesity, Kidney Disease, and Heart Failure Together

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both kidney function and heart health outcomes.

Diabetes Drug Semaglutide Reduces Heart Attacks and Strokes

Diabetes Drug Semaglutide Reduces Heart Attacks and Strokes

Semaglutide, a diabetes drug, significantly lowers the risk of heart attacks and strokes in people with type 2 diabetes.

Advertisement

Rare Disease Drug Turns Human Blood Into Mosquito Poison, Battling Malaria

Rare Disease Drug Turns Human Blood Into Mosquito Poison, Battling Malaria

Nitisinone shows potential as a new tool for malaria control by making human blood lethal to mosquitoes.

Do Statins and Aspirin Pose a Muscle Health Risk for Smokers

Do Statins and Aspirin Pose a Muscle Health Risk for Smokers

In former and current smokers Statins may reduce chest muscle loss in smokers, while aspirin could increase it.

Vedolizumab Outperforms Infliximab in Second-Line Therapy for Ulcerative Colitis

Vedolizumab Outperforms Infliximab in Second-Line Therapy for Ulcerative Colitis

Vedolizumab outperforms infliximab in ulcerative colitis patients who fail first-line treatment, achieving better steroid-free remission and endoscopic improvements by week 14.

Advertisement

Can Engineered Stem Cells End Daily Arthritis Pill Regimens?

Can Engineered Stem Cells End Daily Arthritis Pill Regimens?

Revolutionizing arthritis treatment: Engineered stem cells deliver meds on schedule, synced to your body’s rhythm. Say goodbye to flare-ups!

1 2 3 4 5 6 7 8 ..861

Download Drug News Widget

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional